Research Provides New Clues For Schizophrenia Drug Development

The New England Journal of Medicine Shines Spotlight on Forensic Pathology

Gut Microbiome Composition and Food Insecurity Linked to Risk of Cognitive Impairment in Adults

Mount Sinai Receives $3.8 Million Grant to Study New Synthetic Drugs and Opioid Overdoses in Emergency Departments to Prevent Deaths

New Framework for Characterizing Traumatic Brain Injury To Reveal More Detail About Patient’s Condition and Potential for Recovery

Mount Sinai Researchers Uncover a Promising New Way to Modulate Brain Cell Activity to Potentially Treat Major Depressive Disorder in Adults

Women Whose Sister Experienced Postpartum Psychosis Are More Than 10 Times as Likely to Experience It Themselves, According to New Research

Academy Award-Nominated Movie Helps Researchers Identify Brain Region Biased Towards Drug Cues and Treatment Effects in Individuals With Heroin Use Disorder

Mount Sinai Researchers in Semifinals of $101 Million XPRIZE Healthspan, a Competition Seeking Innovative Approaches to Aging Well

Discovery of Dopamine Receptors in a Previously Overlooked Part of the Brain Sheds Light on the Complex Circuitry for Anxiety and Depression

Mechanism by Which the Brain Weighs Positive vs. Negative Social Experience Is Revealed

Mount Sinai Researchers Discover How Melanoma May Spread to the Brain